SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-22-005888
Filing Date
2022-03-10
Accepted
2022-03-10 17:28:07
Documents
101
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acrx20211231_10k.htm   iXBRL 10-K 2187283
2 EXHIBIT 10.13 ex_343550.htm EX-10.13 9638
3 EXHIBIT 10.31 ex_343559.htm EX-10.31 43540
4 EXHIBIT 23.1 ex_341620.htm EX-23.1 2162
5 EXHIBIT 23.2 ex_341621.htm EX-23.2 6528
6 EXHIBIT 31.1 ex_341622.htm EX-31.1 7843
7 EXHIBIT 31.2 ex_341623.htm EX-31.2 7843
8 EXHIBIT 32.1 ex_341624.htm EX-32.1 6097
  Complete submission text file 0001437749-22-005888.txt   9836580

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA acrx-20211231.xsd EX-101.SCH 97385
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20211231_cal.xml EX-101.CAL 53692
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20211231_def.xml EX-101.DEF 624362
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20211231_lab.xml EX-101.LAB 544925
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20211231_pre.xml EX-101.PRE 663756
95 EXTRACTED XBRL INSTANCE DOCUMENT acrx20211231_10k_htm.xml XML 1505971
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35068 | Film No.: 22730204
SIC: 2834 Pharmaceutical Preparations